These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28530077)

  • 1. [The illegal synthetic cannabinoid drug market in Israel - evolution and new challenges].
    Shapira B; Poperno A; Berkovitz R
    Harefuah; 2016 Sep; 155(9):526-530. PubMed ID: 28530077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan.
    Kikura-Hanajiri R; Kawamura NU; Goda Y
    Drug Test Anal; 2014; 6(7-8):832-9. PubMed ID: 24573957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic Cannabinoid and Mitragynine Exposure of Law Enforcement Agents During the Raid of an Illegal Laboratory - Nevada, 2014.
    Tapp L; Ramsey JG; Wen A; Gerona R
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1291-1294. PubMed ID: 29190268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012-2017: implications for policy and regulatory change.
    Bonny-Noach H; Berkovitz R; Shapira B
    Isr J Health Policy Res; 2020 May; 9(1):14. PubMed ID: 32362275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids.
    Cox AO; Daw RC; Mason MD; Grabenauer M; Pande PG; Davis KH; Wiley JL; Stout PR; Thomas BF; Huffman JW
    J Anal Toxicol; 2012 Jun; 36(5):293-302. PubMed ID: 22582264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
    Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
    Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
    Shanks KG; Dahn T; Behonick G; Terrell A
    J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Spice"--synthetic cannabinoids with dangerous effects].
    Personne M; Westerbergh J; Hammer-Pettersen L
    Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spicing things up: synthetic cannabinoids.
    Spaderna M; Addy PH; D'Souza DC
    Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
    Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
    J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of types of synthetic cannabinoids in narcotic cases assessed by the Council of Forensic Medicine between 2011-2015, Ankara, Turkey.
    Göl E; Çok İ
    Forensic Sci Int; 2017 Nov; 280():124-129. PubMed ID: 29028489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designer drugs – still a threat?
    Rozenek EB; Wilczyńska K; Górska M; Waszkiewicz N
    Przegl Epidemiol; 2019; 73(3):337-347. PubMed ID: 31766831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.
    Law R; Schier J; Martin C; Chang A; Wolkin A;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):618-9. PubMed ID: 26068566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Public Health in Combatting Synthetic Cannabinoid Use in Adolescents.
    Warren KE; Tay S; Wen LS
    J Adolesc Health; 2017 May; 60(5):483-486. PubMed ID: 28433118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of synthetic cannabinoids in serum samples--epidemiology and consumption patterns.
    Jaenicke NJ; Pogoda W; Paulke A; Wunder C; Toennes SW
    Forensic Sci Int; 2014 Sep; 242():81-87. PubMed ID: 25050839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responding to a new wave of high potency synthetic cannabinoids.
    Wilkins C; Rychert M
    N Z Med J; 2018 Sep; 131(1482):6-9. PubMed ID: 30235186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.